in 2012, Insys Therapeutics got approval to sell an ultra powerful opioid for cancer patients with acute pain.
The only problem was that is very expensive, and most cancer patients cannot afford it, unless they got a prescription approved in advance. That process is known as “prior-authorization.”
In efforts to boost sales, Insys reportedly gave the drug to patients who did not have cancer.
According to an investigation by Senator Claire McCaskill (Democrat- Missouri), Insys falsified medical records, misleading insurance companies, and provided kickbacks to doctors in league with the company by using a combination of tactics.
Insys employees were allegedly pretending to be doctors’ offices so that they could fool insurance companies into approving the drug.